share_log

UBS Adjusts Candel Therapeutics Price Target to $8 From $11, Maintains Buy Rating

UBS Adjusts Candel Therapeutics Price Target to $8 From $11, Maintains Buy Rating

瑞銀調整坎德爾治療目標價格從 11 美元至 8 美元,維持買入評級
MT Newswires ·  2022/12/09 10:03

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論